Multimodal Genomic Data Integration for Rare Disease and Cancer Genomic Diagnosis
☄️ GenomeArc collaborating with Oxford Nanopore Technologies, in this webinar will highlight the power on AI in integrating multimodal data for tertiary genome analysis.
✅ Long-read and #multimodal #genomic data analysis improves diagnostic yield by capturing complex variants missed by short-read sequencing. Integrating genome variants, clinical symptoms, single cell transcriptomic, proteomics and other data types provides a fuller biological context, leading to more accurate and actionable diagnoses.
Learn more about GenomeArc: www.genomearc.com
#cancer #rarediseases #cancer #nanopore #tumor #Genomics #CRISPR #GenomeArc #raredisease #DubaiFutureFoundation #FutureOfMedicine #Biotech #PrecisionMedicine #DNA #GeneticEngineering #Innovation #Science #genes
About GenomeArc
GenomeArc stands as a pioneering biotechnology firm dedicated to offering sophisticated genomic analytical assistance for the resolution of clinical genetic tests for oncology and rare diseases. Given the intricate nature of genetic diseases, a comprehensive and integrated data support system becomes imperative for the nuanced interpretation/classification of variants and their associations with diseases. Leveraging the cutting-edge capabilities of our genomic medicine platform, GenomeArc Horizon®, we offer a robust and integrated framework for variant interpretation enabling diagnosis, ensuring a thorough understanding of the genetic landscape and enhancing the efficiency of genomic medicine applications.